Previous 10 | Next 10 |
YAVNE, Israel and CAMBRIDGE, Mass., Aug. 25, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD) and its U.S. commercial partner Vericel Corporation (NASDAQ: VCEL) today announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant...
Image source: The Motley Fool. Vericel (NASDAQ: VCEL) Q2 2020 Earnings Call Aug 05, 2020 , 8:30 a.m. ET Operator Continue reading
Vericel Corporation (VCEL) Q2 2020 Earnings Conference Call August 05, 2020, 08:30 AM ET Company Participants Gerard Michel - CFO Nick Colangelo - President and CEO Conference Call Participants Ryan Zimmerman - BTIG Danielle Antalffy - SVB Leerink Chad Messer - Needham an...
The following slide deck was published by Vericel Corporation in conjunction with their 2020 Q2 earnings Read more ...
Vericel (NASDAQ: VCEL ) : Q2 GAAP EPS of -$0.18 beats by $0.02 . More news on: Vericel Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...
Product Revenues of $20.0 Million Reported for the Second Quarter Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets,...
CAMBRIDGE, Mass., July 22, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the following webcast and conference call to discuss its second-quarter 2020 financial results and busi...
Quick Take ACell ( ACLL ) has filed to raise $75 million from the sale of its common stock, according to an amended registration statement . The company develops and sells wound treatment systems for various tissue care applications. ACLL was growing revenue sharply but has since felt t...
Vericel (NASDAQ: VCEL ) announces preliminary Q2 results and business updates. More news on: Vericel Corporation, Healthcare stocks news, Read more ...
CAMBRIDGE, Mass., July 09, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced preliminary financial results for the quarter ended June 30, 2020, and provided business updates. P...
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the appointment of Karen Mahoney as Chief Human Resources Officer following the retirement of Heidi Hassen, w...
CAMBRIDGE, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it will report its second-quarter 2024 financial results on Thursday, August 1, 2024. Vericel’s m...
2024-07-08 00:00:04 ET Ryan Zimmerman from BTIG issued a price target of $56.00 for VCEL on 2024-07-05 10:09:00. The adjusted price target was set to $56.00. At the time of the announcement, VCEL was trading at $46.68. The overall price target consensus is at $48.00 with...